Trial Profile
No correction vs. new formula for setting the anthropometric characteristics for Target Controlled Infusion (TCI) of remifentanil in obese patients. [Nessuna correzione vs nuova formula per l'mpostazione delle caratteristiche antropometriche per Target Controlled Infusion (TCI) di remifentanil in pazienti obesi.]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 02 Apr 2012 New trial record